advertisement

---

Prokosch-Willing V 15

Showing records 1 to 15 | Display all abstracts from Prokosch-Willing V

100646 Adverse Effects and Safety in Glaucoma Patients: Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD)-A Delphi Consensus Statement
Thein AS
American Journal of Ophthalmology 2022; 241: 190-197

---

100259 Short-term changes in Bruch's membrane opening-based morphometrics during the first week after trabeculectomy
Gietzelt C
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 260: 3321-3329

---

100646 Adverse Effects and Safety in Glaucoma Patients: Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD)-A Delphi Consensus Statement
Hedengran A
American Journal of Ophthalmology 2022; 241: 190-197

---

100259 Short-term changes in Bruch's membrane opening-based morphometrics during the first week after trabeculectomy
Lüke JN
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 260: 3321-3329

---

100646 Adverse Effects and Safety in Glaucoma Patients: Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD)-A Delphi Consensus Statement
Azuara-Blanco A
American Journal of Ophthalmology 2022; 241: 190-197

---

100259 Short-term changes in Bruch's membrane opening-based morphometrics during the first week after trabeculectomy
Adler W; Dietlein TS
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 260: 3321-3329

---

100646 Adverse Effects and Safety in Glaucoma Patients: Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD)-A Delphi Consensus Statement
Arita R
American Journal of Ophthalmology 2022; 241: 190-197

---

100259 Short-term changes in Bruch's membrane opening-based morphometrics during the first week after trabeculectomy
Lappas A
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 260: 3321-3329

---

100646 Adverse Effects and Safety in Glaucoma Patients: Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD)-A Delphi Consensus Statement
Cvenkel B; Gazzard G
American Journal of Ophthalmology 2022; 241: 190-197

---

100259 Short-term changes in Bruch's membrane opening-based morphometrics during the first week after trabeculectomy
Prokosch-Willing V; Roters S
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 260: 3321-3329

---

100646 Adverse Effects and Safety in Glaucoma Patients: Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD)-A Delphi Consensus Statement
Heegaard S; de Paiva CS
American Journal of Ophthalmology 2022; 241: 190-197

---

100259 Short-term changes in Bruch's membrane opening-based morphometrics during the first week after trabeculectomy
Heindl LM
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 260: 3321-3329

---

100646 Adverse Effects and Safety in Glaucoma Patients: Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD)-A Delphi Consensus Statement
Petrovski G
American Journal of Ophthalmology 2022; 241: 190-197

---

100259 Short-term changes in Bruch's membrane opening-based morphometrics during the first week after trabeculectomy
Cursiefen C; Enders P
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 260: 3321-3329

---

100646 Adverse Effects and Safety in Glaucoma Patients: Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD)-A Delphi Consensus Statement
Prokosch-Willing V; Utheim TP; Virgili G; Kolko M
American Journal of Ophthalmology 2022; 241: 190-197

---